Eleven Biotherapeutics Reports Third Quarter 2015 Financial Results

by Business Wire • 2015/11/04 • 0 Comments

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Eleven Biotherapeutics Reports Third Quarter 2015 Financial Results. Management to host conference call today at 8:30 a.m. ET

← NovaBay Pharmaceuticals Completes 34 Patient Phase 2B Clinical Study

Allergan signs licensing agreement with Mimetogen to develop, commercialize tavilermide for treatment of dry eye disease →

Post navigation